PharmaResearch Co Ltd
KOSDAQ:214450
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
KR |
|
Central Bank of India Ltd
NSE:CENTRALBK
|
IN |
|
Minerals Technologies Inc
NYSE:MTX
|
US |
|
I
|
IST Ltd
BSE:508807
|
IN |
|
Geely Automobile Holdings Ltd
HKEX:175
|
HK |
|
REALIA Business SA
MAD:RLIA
|
ES |
|
T
|
Tupperware Brands Corp
XMUN:TUP
|
US |
|
Innergex Renewable Energy Inc
TSX:INE
|
CA |
|
Elis SA
PAR:ELIS
|
FR |
|
Innospec Inc
NASDAQ:IOSP
|
US |
|
Delivery Hero SE
XETRA:DHER
|
DE |
|
Ballard Power Systems Inc
TSX:BLDP
|
CA |
|
B
|
Bajaj Steel Industries Ltd
BSE:507944
|
IN |
Wall St Price Targets
Price Targets Summary
PharmaResearch Co Ltd
According to Wall Street analysts, the average 1-year price target for PharmaResearch Co Ltd is 518 994.55 KRW with a low forecast of 333 300 KRW and a high forecast of 752 850 KRW.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PharmaResearch Co Ltd's stock price target?
Price Target
518 994.55
KRW
According to Wall Street analysts, the average 1-year price target for PharmaResearch Co Ltd is 518 994.55 KRW with a low forecast of 333 300 KRW and a high forecast of 752 850 KRW.
What is the Revenue forecast for PharmaResearch Co Ltd?
Projected CAGR
20%
Over the last 11 years, the compound annual growth rate for Revenue has been 32%. The projected CAGR for the next 3 years is 20%.
What is the Operating Income forecast for PharmaResearch Co Ltd?
Projected CAGR
32%
Over the last 11 years, the compound annual growth rate for Operating Income has been 31%. The projected CAGR for the next 3 years is 32%.
What is the Net Income forecast for PharmaResearch Co Ltd?
Projected CAGR
18%
Over the last 11 years, the compound annual growth rate for Net Income has been 30%. The projected CAGR for the next 3 years is 18%.
